- HOME
- Laboratories
- Genetic Diagnosis
- Publications
- Original articles
Update :
2017-06-27
Contents
Original articles
2017｜2016｜2015｜2014｜2013｜2012｜2011｜2009｜2008｜2007｜2006
2017
- K. Hosoya, S. Matsusaka, T. Kashiwada, K. Suzuki, N. Ureshino, A. Sato, Y. Miki, K. Kitera, M. Hirai, K. Hatake, S. Kimura and N. Sueoka-Aragane.
- Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
Pathology oncology research, in press (2017) - C. T. Nguyen, T. Okamura, K. I. Morita, S. Yamaguchi, H. Harada, Y. Miki, T. Izumo, K. Kayamori, A. Yamaguchi and K. Sakamoto.
- LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Journal of oral pathology & medicine, 46, 223-231 (2017) - M. Takaoka, S. Ito, Y. Miki and A. Nakanishi.
- FKBP51 regulates cell motility and invasion via RhoA signaling.
Cancer Science, 108, 380-389 (2017)
2016
- Osumi, H., Shinozaki, E., Suenaga, M., Matsusaka, S., Konishi, T., Akiyoshi, T., Fujimoto, Y., Nagayama, S., Fukunaga, Y., Ueno, M., Mise, Y., Ishizawa, T., Inoue, Y., Takahashi, Y., Saiura, A., Uehara, H., Mun, M., Okumura, S., Mizunuma, N., Miki, Y., Yamaguchi, T.
- RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
Int J Cancer, in press (2016) - Pal, S.K., Nguyen, C.T., Morita, K.I., Miki, Y., Kayamori, K., Yamaguchi, A., Sakamoto, K.
- THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
J Oral Pathol Med, in press (2016) - Wang, J., Ding, Q., Fujimori, H., Motegi, A., Miki, Y., Masutani, M.
- Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors.
Oncotarget, 7, 7701-7714 (2016) - R. Khanom, C. T. Nguyen, K. Kayamori, X. Zhao, K. Morita, Y. Miki, K. Katsube, A. Yamaguchi and K. Sakamoto.
- Keratin 17 Is induced in oral cancer and facilitates tumor growth.
PloS one, 11, e0161163 (2016) - S. Malik, H. Saito, M. Takaoka, Y. Miki and A. Nakanishi.
- BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.
Cell cycle, 15, 2145-2156 (2016)
2015
- Nakamura, S., Takahashi, M., Tozaki, M., Nakayama, T., Nomizu, T., Miki, Y., Murakami, Y., Aoki, D., Iwase, T., Nishimura, S., Yamauchi, H., Ohsumi, S., Baba, S., Shimizu, T.
- Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.
Breast Cancer, 22, 462-468 (2015)
2014
- Takaoka, M., Saito, H., Takenaka, K., Miki, Y., Nakanishi, A.
- BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC.
Cancer Res, 74, 1518-1528 (2014) - Wada, Y., Matsuura, M., Sugawara, M., Ushijima, M., Miyata, S., Nagasaki, K., Noda, T., Miki, Y.
- Development of detection method for novel fusion gene using GeneChip exon array.
J Clin Bioinforma, 4, 3 (2014) - Ishiba, T., Nagahara, M., Nakagawa, T., Sato, T., Ishikawa, T., Uetake, H., Sugihara, K., Miki, Y., Nakanishi, A.
- Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion.
Sci Rep, 4, 7069 (2014) - Kimura, H., Miki, Y., Nakanishi, A.
- Centrosomes at M phase act as a scaffold for the accumulation of intracellular ubiquitinated proteins.
Cell Cycle, 13, 1928-1937 (2014) - Tan, T.Z., Miow, Q.H., Miki, Y., Noda, T., Mori, S., Huang, R.Y., Thiery, J.P.
- Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
EMBO Mol Med, 6, 1279-1293 (2014)
2013
- Kawazu, M., Ueno, T., Kontani, K., Ogita, Y., Ando, M., Fukumura, K., Yamato, A., Soda, M., Takeuchi, K., Miki, Y., Yamaguchi, H., Yasuda, T., Naoe, T., Yamashita, Y., Katada, T., Choi, Y.L., Mano, H.
- Transforming mutations of RAC guanosine triphosphatases in human cancers.
Proc Natl Acad Sci U S A, 110, 3029-3034 (2013) - Low, S.K., Takahashi, A., Ashikawa, K., Inazawa, J., Miki, Y., Kubo, M., Nakamura, Y., Katagiri, T.
- Genome-wide association study of breast cancer in the Japanese population.
PLoS One, 8, e76463 (2013) - Nakamura, S., Takahashi, M., Tozaki, M., Nakayama, T., Nomizu, T., Miki, Y., Murakami, Y., Aoki, D., Iwase, T., Nishimura, S., Yamauchi, H., Ohsumi, S., Baba, S., Shimizu, T.
- Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.
Breast Cancer, in press (2013) - Wali, N., Hosokawa, K., Malik, S., Saito, H., Miyaguchi, K., Imajoh-Ohmi, S., Miki, Y., Nakanishi, A.
- Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP).
Biochem Biophys Res Commun, 443, 1148-1154 (2013)
2012
- Iyevleva, A.G., Kuligina, E., Mitiushkina, N.V., Togo, A.V., Miki, Y., Imyanitov, E.N.
- High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas.
Breast Cancer Res Treat, 131, 1049-1059 (2012) - Satoh, Y., Sugai, S., Uehara, H., Mun, M., Sakao, Y., Okumura, S., Nakagawa, K., Ishikawa, Y., Miki, Y., Miyata, S.
- Clinical impact of intraoperative detection of carcinoembryonic antigen (CEA) in mRNA in pleural lavage specimens from non-small cell lung cancer.
Thorac Cardiovasc Surg, 60, 533-540 (2012) - Wang, L., Tsutsumi, S., Kawaguchi, T., Nagasaki, K., Tatsuno, K., Yamamoto, S., Sang, F., Sonoda, K., Sugawara, M., Saiura, A., Hirono, S., Yamaue, H., Miki, Y., Isomura, M., Totoki, Y., Nagae, G., Isagawa, T., Ueda, H., Murayama-Hosokawa, S., Shibata, T., Sakamoto, H., Kanai, Y., Kaneda, A., Noda, T., Aburatani, H.
- Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.
Genome Res, 22, 208-219 (2012)
2011
- Ito, Y., Nagasaki, K., Miki, Y., Iwase, T., Akiyama, F., Matsuura, M., Horii, R., Makita, M., Tokudome, N., Ushijima, M., Yoshimoto, M., Takahashi, S., Noda, T., Hatake, K.
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
Cancer Sci, 102, 130-136 (2011) - Wang, H.F., Takenaka, K., Nakanishi, A., Miki, Y.
- BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Cancer Res, 71, 68-77 (2011)
2009
- Niwa, T., Saito, H., Imajoh-ohmi, S., Kaminishi, M., Seto, Y., Miki, Y., Nakanishi, A.
- BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization.
Cancer Sci, 100, 2115-2125 (2009)
2008
- Hirai, Y., Banno, K., Suzuki, M., Ichikawa, Y., Udagawa, Y., Sugano, K., Miki, Y.
- Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer.
Cancer Sci, 99, 1715-1719 (2008) - Izawa, N., Matsumoto, S., Manabe, J., Tanizawa, T., Hoshi, M., Shigemitsu, T., Machinami, R., Kanda, H., Takeuchi, K., Miki, Y., Arai, M., Shirahama, S., Kawaguchi, N.
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene.
Int J Clin Oncol, 13, 78-82 (2008) - Shinagawa, H., Miki, Y., Yoshida, K.
- BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.
Antioxid Redox Signal, 10, 939-949 (2008) - Sugano, K., Nakamura, S., Ando, J., Takayama, S., Kamata, H., Sekiguchi, I., Ubukata, M., Kodama, T., Arai, M., Kasumi, F., Hirai, Y., Ikeda, T., Jinno, H., Kitajima, M., Aoki, D., Hirasawa, A., Takeda, Y., Yazaki, K., Fukutomi, T., Kinoshita, T., Tsunematsu, R., Yoshida, T., Izumi, M., Umezawa, S., Yagata, H., Komatsu, H., Arimori, N., Matoba, N., Gondo, N., Yokoyama, S., Miki, Y.
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.
Cancer Sci, 99, 1967-1976 (2008) - Tanaka, S., Arii, S., Yasen, M., Mogushi, K., Su, N.T., Zhao, C., Imoto, I., Eishi, Y., Inazawa, J., Miki, Y., Tanaka, H.
- Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy.
Br J Surg, 95, 611-619 (2008) - Tomiyoshi, G., Nakanishi, A., Takenaka, K., Yoshida, K., Miki, Y.
- Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.
Cancer Sci, 99, 747-754 (2008)
2007
- Fujisawa, H., Isomura, M., Eguchi, S., Ushijima, M., Miyata, S., Miki, Y., Matsuura, M.
- Identifying haplotype block structure using an ancestor-derived model.
J Hum Genet, 52, 738-746 (2007) - Han, X., Saito, H., Miki, Y., Nakanishi, A.
- A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2.
Oncogene, (2007) - Horii, R., Akiyama, F., Ito, Y., Matsuura, M., Miki, Y., Iwase, T.
- Histological features of breast cancer, highly sensitive to chemotherapy.
Breast Cancer, 14, 393-400 (2007) - Liu, H., Lu, Z.G., Miki, Y., Yoshida, K.
- Protein kinase C δ induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage.
Mol Cell Biol, 27, 8480-8491 (2007) - Maekawa, T., Shinagawa, T., Sano, Y., Sakuma, T., Nomura, S., Nagasaki, K., Miki, Y., Saito-Ohara, F., Inazawa, J., Kohno, T., Yokota, J., Ishii, S.
- Reduced levels of ATF-2 predispose mice to mammary tumors.
Mol Cell Biol, 27, 1730-1744 (2007) - Nakanishi, A., Han, X., Saito, H., Taguchi, K., Ohta, Y., Imajoh-Ohmi, S., Miki, Y.
- Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.
Biochem Biophys Res Commun, 355, 34-40 (2007) - Nguyen, S.T., Hasegawa, S., Tsuda, H., Tomioka, H., Ushijima, M., Noda, M., Omura, K., Miki, Y.
- Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma.
Cancer Sci, 98, 740-746 (2007) - Noda, H., Miyaji, Y., Nakanishi, A., Konishi, F., Miki, Y.
- Frequent reduced expression of α-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers.
Br J Cancer, 96, 383-390 (2007) - Oishi, Y., Nagasaki, K., Miyata, S., Matsuura, M., Nishimura, S., Akiyama, F., Iwai, T., Miki, Y.
- Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer.
J Hum Genet, 52, 271-279 (2007) - Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., Yoshida, K.
- DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
Mol Cell, 25, 725-738 (2007) - Yamaguchi, T., Kimura, J., Miki, Y., Yoshida, K.
- The deubiquitinating enzyme USP11 controls an IκB kinase alpha (IKKα)-p53 signaling pathway in response to tumor necrosis factor α (TNFα).
J Biol Chem, 282, 33943-33948 (2007) - Yamaguchi, T., Miki, Y., Yoshida, K.
- Protein kinase C δ activates IκB-kinase α to induce the p53 tumor suppressor in response to oxidative stress.
Cell Signal, 19, 2088-2097 (2007)
2006
- Hayashi, T., Arai, M., Ueno, M., Kinoshita, H., Tada, Y., Koizumi, K., Miki, Y., Yamaguchi, T., Kato, Y., Utsunomiya, J., Muto, T., Sugihara, K.
- Frequency of immunohistochemical loss of mismatch repair protein in double primary cancers of the colorectum and stomach in Japan.
Dis Colon Rectum, 49, S23-29 (2006) - Nagasaki, K., Miki, Y.
- Gene expression profiling of breast cancer.
Breast Cancer, 13, 2-7 (2006) - Noda, H., Kato, Y., Yoshikawa, H., Arai, M., Togashi, K., Nagai, H., Konishi, F., Miki, Y.
- Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
J Exp Clin Cancer Res, 25, 235-242 (2006) - Tokairin, Y., Kakinuma, S., Arai, M., Nishimura, M., Okamoto, M., Ito, E., Akashi, M., Miki, Y., Kawano, T., Iwai, T., Shimada, Y.
- Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC.
Int J Exp Pathol, 87, 89-99 (2006) - Yoshida, K., Liu, H., Miki, Y.
- Protein kinase C δ regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage.
J Biol Chem, 281, 5734-5740 (2006) - Yoshida, K., Yamaguchi, T., Shinagawa, H., Taira, N., Nakayama, K.I., Miki, Y.
- Protein kinase C δ activates topoisomerase IIα to induce apoptotic cell death in response to DNA damage.
Mol Cell Biol, 26, 3414-3431 (2006)
